Insider Trading › AGIO › Insiders
AGIOS PHARMACEUTICALS, INC.
AGIO·Nasdaq·
United States·Insider activity
United States·Insider activity$31.72
+0.47 (+1.50%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
AGIO
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AGIOS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, AGIO insiders filed 0 purchases ($0) and 2 sales ($1.1M) on the open market, by 1 insider. Newest filing Aug 6, 2026 (2 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by AGIO insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$1.1MSales · 180 days
622Open-market transactions on record
1Insiders filing · 180 days
Purchases (code P) and sales (code S) of AGIO common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
622 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Gheuens SarahChief Medical Officer | Sale | −30.0K | $30.48 | $914K | 54.6Kdirect | Aug 4, 2026 | Aug 6, 2026 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −4,007 | $37.56 | $151K | 84.6Kdirect | Jul 1, 2026 | Jul 2, 2026 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −3,280 | $34.71 | $114K | 49.3Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −2,940 | $34.71 | $102K | 80.3Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −3,141 | $34.71 | $109K | 55.0Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −3,262 | $34.71 | $113K | 46.8Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Viswanadhan KrishnanChief Corp Dev & Strategy | Sale | −2,959 | $34.71 | $103K | 10.3Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −6,596 | $34.71 | $229K | 184.5Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −12.5K | $34.71 | $433K | 177.6Kdirect | Apr 2, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Viswanadhan KrishnanChief Corp Dev & Strategy | Sale | −2,959 | $27.80 | $82K | 5,141direct | Mar 5, 2026 | Mar 9, 2026 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −5,272 | $28.88 | $152K | 868direct | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −5,918 | $28.96 | $171K | 164.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −8,267 | $28.96 | $239K | 157.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −3,870 | $28.96 | $112K | 147.7Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,163 | $28.96 | $34K | 44.1Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,187 | $28.96 | $34K | 41.3Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,681 | $28.96 | $49K | 38.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,187 | $28.96 | $34K | 34.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,187 | $28.96 | $34K | 74.4Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,681 | $28.96 | $49K | 71.6Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,187 | $28.96 | $34K | 67.6Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,573 | $28.96 | $46K | 49.3Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,187 | $28.96 | $34K | 45.6Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,681 | $28.96 | $49K | 42.8Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −594 | $28.96 | $17K | 38.8Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −1,187 | $28.96 | $34K | 41.6Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −1,681 | $28.96 | $49K | 38.8Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −798 | $28.96 | $23K | 6,140direct | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −727 | $28.96 | $21K | 4,243direct | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −698 | $28.96 | $20K | 2,595direct | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −2,872 | $27.02 | $78K | 34.8Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −2,932 | $27.09 | $79K | 31.7Kdirect | Dec 30, 2025 | Jan 2, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −6,230 | $27.09 | $169K | 143.1Kdirect | Dec 30, 2025 | Jan 2, 2026 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −12.5K | $27.09 | $338K | 136.6Kdirect | Dec 30, 2025 | Jan 2, 2026 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −2,932 | $27.09 | $79K | 64.8Kdirect | Dec 30, 2025 | Jan 2, 2026 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −2,932 | $27.09 | $79K | 29.2Kdirect | Dec 30, 2025 | Jan 2, 2026 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −2,932 | $27.09 | $79K | 37.4Kdirect | Dec 30, 2025 | Jan 2, 2026 | Form 4 ↗ |
| Scadden DavidDirector | Sale | −200 | $43.84 | $9K | 17.6Kdirect | Nov 12, 2025 | Nov 14, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −2,454 | $43.78 | $107K | 61.7Kdirect | Nov 11, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −200 | $43.81 | $9K | 61.7Kdirect | Oct 30, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −3,302 | $43.92 | $145K | 61.7Kdirect | Oct 27, 2025 | Oct 29, 2025 | Form 4 ↗ |
| Scadden DavidDirector | Sale | −200 | $41.00 | $8K | 17.6Kdirect | Oct 8, 2025 | Oct 10, 2025 | Form 4 ↗ |
| Scadden DavidDirector | Sale | −200 | $40.00 | $8K | 17.6Kdirect | Sep 30, 2025 | Oct 2, 2025 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −3,651 | $36.77 | $134K | 33.9Kdirect | Sep 26, 2025 | Sep 30, 2025 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −8,546 | $36.87 | $315K | 868direct | Sep 5, 2025 | Sep 9, 2025 | Form 4 ↗ |
| Scadden DavidDirector | Sale | −200 | $40.00 | $8K | 17.6Kdirect | Aug 27, 2025 | Aug 29, 2025 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −11.1K | $36.67 | $406K | 123.5Kdirect | Aug 8, 2025 | Aug 12, 2025 | Form 4 ↗ |
| Scadden DavidDirector | Sale | −1,400 | $40.00 | $56K | 17.6Kdirect | Jul 10, 2025 | Jul 15, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −847 | $38.76 | $33K | 61.3Kdirect | Jul 9, 2025 | Jul 11, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −11.1K | $37.93 | $420K | 62.1Kdirect | Jul 9, 2025 | Jul 11, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −4,091 | $34.17 | $140K | 61.3Kdirect | Jul 1, 2025 | Jul 3, 2025 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −2,799 | $33.54 | $94K | 28.6Kdirect | Jun 24, 2025 | Jun 26, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −2,909 | $33.54 | $98K | 57.0Kdirect | Jun 24, 2025 | Jun 26, 2025 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,780 | $33.54 | $60K | 30.0Kdirect | Jun 24, 2025 | Jun 26, 2025 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −2,770 | $33.54 | $93K | 26.1Kdirect | Jun 24, 2025 | Jun 26, 2025 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −6,229 | $33.54 | $209K | 111.9Kdirect | Jun 24, 2025 | Jun 26, 2025 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −12.5K | $33.54 | $418K | 105.4Kdirect | Jun 24, 2025 | Jun 26, 2025 | Form 4 ↗ |
| FOUSE JACQUALYN ADirector | Sale | −7,497 | $25.90 | $194K | 149.2Kdirect | Apr 10, 2025 | Apr 10, 2025 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,681 | $35.54 | $60K | 25.4Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,187 | $35.54 | $42K | 21.5Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,137 | $35.54 | $40K | 18.6Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,681 | $35.54 | $60K | 25.8Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −594 | $35.54 | $21K | 21.8Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −1,681 | $35.54 | $60K | 22.9Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −8,794 | $35.54 | $313K | 92.3Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −4,153 | $35.54 | $148K | 83.1Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,681 | $35.54 | $60K | 53.9Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,187 | $35.54 | $42K | 49.9Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,137 | $35.54 | $40K | 47.1Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −727 | $35.54 | $26K | 9,414direct | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −697 | $35.54 | $25K | 7,691direct | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −231 | $35.54 | $8K | 6,038direct | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −2,272 | $34.39 | $78K | 5,437direct | Feb 5, 2025 | Feb 5, 2025 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −2,804 | $32.18 | $90K | 18.9Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Scadden DavidDirector | Sale | −200 | $46.28 | $9K | 15.5Kdirect | Dec 11, 2024 | Dec 13, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −772 | $56.09 | $43K | 813direct | Nov 8, 2024 | Nov 13, 2024 | Form 4 ↗ |
| Ballal Rahul D.Director | Sale | −1,500 | $59.21 | $89K | 7,992direct | Nov 8, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Ballal Rahul D.Director | Sale | −4,929 | $58.57 | $289K | 9,492direct | Nov 8, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Ballal Rahul D.Director | Sale | −3,571 | $57.24 | $204K | 14.4Kdirect | Nov 8, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Ballal Rahul D.Director | Sale | −1,868 | $54.41 | $102K | 7,992direct | Nov 7, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Ballal Rahul D.Director | Sale | −8,132 | $53.32 | $434K | 9,860direct | Nov 7, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −8,341 | $52.56 | $438K | 15.7Kdirect | Nov 7, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −13.4K | $52.00 | $697K | 24.0Kdirect | Nov 7, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −2,542 | $49.03 | $125K | 20.2Kdirect | Sep 26, 2024 | Sep 30, 2024 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −11.1K | $42.75 | $474K | 78.8Kdirect | Aug 8, 2024 | Aug 12, 2024 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −3,705 | $43.85 | $162K | 43.7Kdirect | Jul 1, 2024 | Jul 3, 2024 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −12.1K | $48.84 | $592K | 67.2Kdirect | Jun 5, 2024 | Jun 7, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −1,362 | $44.39 | $60K | 1,524direct | Jun 3, 2024 | Jun 5, 2024 | Form 4 ↗ |
| FOUSE JACQUALYN ADirector | Sale | −7,791 | $27.55 | $215K | 137.4Kdirect | Apr 10, 2024 | Apr 10, 2024 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −1,285 | $31.62 | $41K | 5,524direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −4,415 | $31.99 | $141K | 6,809direct | Mar 6, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −300 | $32.21 | $10K | 11.2Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −1,913 | $31.75 | $61K | 2,886direct | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,349 | $32.57 | $44K | 39.1Kdirect | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,293 | $32.57 | $42K | 36.4Kdirect | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −672 | $32.57 | $22K | 14.8Kdirect | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −919 | $32.57 | $30K | 4,799direct | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −295 | $32.57 | $10K | 3,368direct | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −4,156 | $32.57 | $135K | 53.8Kdirect | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,349 | $32.57 | $44K | 37.2Kdirect | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,293 | $32.57 | $42K | 34.5Kdirect | Mar 5, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −57.5K | $34.89 | $2.0M | 122.9Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −11.9K | $33.60 | $398K | 122.9Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −20.4K | $33.19 | $677K | 122.9Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −47.7K | $33.05 | $1.6M | 122.9Kdirect | Feb 23, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −504 | $26.63 | $13K | 2,741direct | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −642 | $25.14 | $16K | 33.4Kdirect | Feb 14, 2024 | Feb 14, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −545 | $25.14 | $14K | 31.7Kdirect | Feb 14, 2024 | Feb 14, 2024 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −273 | $25.14 | $7K | 3,245direct | Feb 14, 2024 | Feb 14, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,708 | $21.64 | $37K | 30.4Kdirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,708 | $21.64 | $37K | 31.9Kdirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,886 | $21.64 | $41K | 13.1Kdirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| FOUSE JACQUALYN ADirector | Sale | −10.7K | $21.64 | $232K | 129.3Kdirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −7,635 | $21.64 | $165K | 49.4Kdirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −1,618 | $21.64 | $35K | 13.2Kdirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −12.1K | $22.99 | $277K | 40.1Kdirect | Jan 9, 2024 | Jan 9, 2024 | Form 4 ↗ |
| FOUSE JACQUALYN ADirector | Sale | −8,391 | $22.99 | $193K | 116.1Kdirect | Jan 9, 2024 | Jan 9, 2024 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,163 | $22.99 | $27K | 26.3Kdirect | Jan 9, 2024 | Jan 9, 2024 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,789 | $22.99 | $41K | 27.9Kdirect | Jan 9, 2024 | Jan 9, 2024 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −2,902 | $22.32 | $65K | 9,404direct | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −2,179 | $24.79 | $54K | 9,575direct | Sep 28, 2023 | Sep 28, 2023 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −6,395 | $26.28 | $168K | 23.9Kdirect | Aug 17, 2023 | Aug 21, 2023 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −25.0K | $25.96 | $649K | 11.5Kdirect | Aug 9, 2023 | Aug 11, 2023 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −10.2K | $25.48 | $259K | 26.6Kdirect | Aug 8, 2023 | Aug 10, 2023 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −2,918 | $25.39 | $74K | 2,741direct | Aug 7, 2023 | Aug 9, 2023 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −1,232 | $26.26 | $32K | 5,659direct | Aug 1, 2023 | Aug 2, 2023 | Form 4 ↗ |
| Burns James WilliamChief Legal Officer | Sale | −1,707 | $28.36 | $48K | 30.3Kdirect | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| FOUSE JACQUALYN ADirector | Sale | −10.7K | $28.36 | $304K | 107.0Kdirect | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Gheuens SarahChief Medical Officer | Sale | −1,707 | $28.36 | $48K | 24.2Kdirect | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Goff BrianChief Executive Officer · Director | Sale | −11.4K | $28.36 | $325K | 14.1Kdirect | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Jones CeciliaChief Financial Officer | Sale | −1,597 | $28.36 | $45K | 3,783direct | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Milanova TsvetaChief Commercial Officer | Sale | −1,618 | $28.36 | $46K | 3,831direct | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −16.4K | $22.85 | $374K | 117.9Kdirect | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −20.0K | $22.15 | $443K | 117.9Kdirect | Mar 27, 2023 | Mar 29, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −1,667 | $22.72 | $38K | 117.9Kdirect | Mar 13, 2023 | Mar 15, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −18.3K | $22.47 | $412K | 119.5Kdirect | Mar 13, 2023 | Mar 15, 2023 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −504 | $24.29 | $12K | 2,741direct | Mar 3, 2023 | Mar 7, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −20.0K | $25.37 | $507K | 117.9Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −233 | $27.21 | $6K | 2,668direct | Feb 16, 2023 | Feb 21, 2023 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −504 | $28.59 | $14K | 2,901direct | Feb 14, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −20.0K | $28.62 | $572K | 117.9Kdirect | Feb 13, 2023 | Feb 15, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −3,300 | $29.88 | $99K | 117.9Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −16.7K | $29.22 | $488K | 121.2Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −1,034 | $29.49 | $30K | 117.9Kdirect | Jan 17, 2023 | Jan 19, 2023 | Form 4 ↗ |
| Schenkein David PDirector | Sale | −19.0K | $28.82 | $547K | 118.9Kdirect | Jan 17, 2023 | Jan 19, 2023 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −108 | $30.00 | $3K | 2,549direct | Feb 25, 2022 | Mar 1, 2022 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −233 | $30.81 | $7K | 2,549direct | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| Washburn Theodore James Jr.Principal Accounting Officer | Sale | −504 | $31.25 | $16K | 2,782direct | Feb 14, 2022 | Feb 16, 2022 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −1,777 | $61.61 | $109K | 0direct | Jun 21, 2021 | Jun 23, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −48.5K | $60.11 | $2.9M | 15.5Kdirect | Jun 18, 2021 | Jun 22, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −2,502 | $60.02 | $150K | 15.5Kdirect | Jun 17, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −20.9K | $60.06 | $1.3M | 15.5Kdirect | Jun 10, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −7,149 | $60.16 | $430K | 15.5Kdirect | Jun 9, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −6,675 | $60.07 | $401K | 15.5Kdirect | Jun 8, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −4,268 | $60.04 | $256K | 15.5Kdirect | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Miles DarrinChief Commercial Officer | Sale | −3,462 | $55.41 | $192K | 7,209direct | May 14, 2021 | May 18, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −14.4K | $55.11 | $794K | 15.5Kdirect | Apr 20, 2021 | Apr 21, 2021 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −3,210 | $55.16 | $177K | 15.5Kdirect | Apr 19, 2021 | Apr 21, 2021 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −1,118 | $55.89 | $62K | 0direct | Apr 16, 2021 | Apr 20, 2021 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −991 | $54.00 | $54K | 1,118direct | Apr 15, 2021 | Apr 16, 2021 | Form 4 ↗ |
| Miles DarrinChief Commercial Officer | Sale | −500 | $48.58 | $24K | 10.7Kdirect | Mar 5, 2021 | Mar 16, 2021 | Form 4 ↗ |
| Miles DarrinChief Commercial Officer | Sale | −2,200 | $47.99 | $106K | 11.2Kdirect | Mar 1, 2021 | Mar 16, 2021 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −250 | $39.93 | $10K | 184direct | Sep 2, 2020 | Sep 4, 2020 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −3,583 | $50.01 | $179K | 8,306direct | May 20, 2020 | May 21, 2020 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −345 | $47.30 | $16K | 184direct | Mar 2, 2020 | Mar 4, 2020 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −472 | $47.12 | $22K | 184direct | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −2,427 | $53.37 | $130K | 184direct | Feb 20, 2020 | Feb 24, 2020 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −7,100 | $50.16 | $356K | 1,650direct | Feb 13, 2020 | Feb 18, 2020 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −621 | $50.02 | $31K | 1,650direct | Feb 11, 2020 | Feb 13, 2020 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −35.4K | $50.10 | $1.8M | 1,650direct | Feb 4, 2020 | Feb 6, 2020 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −14.2K | $50.03 | $710K | 1,650direct | Feb 4, 2020 | Feb 6, 2020 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −2,950 | $50.09 | $148K | 184direct | Dec 26, 2019 | Dec 30, 2019 | Form 4 ↗ |
| FOUSE JACQUALYN AChief Executive Officer · Director | Purchase | +40.3K | n/c | — | 41.7Kdirect | Nov 13, 2019 | Nov 15, 2019 | Form 4 ↗ |
| Schenkein David PDirector | Purchase | +8,064 | n/c | — | 97.6Kdirect | Nov 13, 2019 | Nov 15, 2019 | Form 4 ↗ |
| Celgene Alpine Investment Co., LLC10% owner | Purchase | +403.2K | n/c | — | 1.8Mdirect | Nov 12, 2019 | Nov 14, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −599 | $68.12 | $41K | 26.5Kdirect | Apr 5, 2019 | Apr 9, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −2,401 | $67.61 | $162K | 27.1Kdirect | Apr 5, 2019 | Apr 9, 2019 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −100 | $68.72 | $7K | 7,238direct | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,500 | $68.09 | $102K | 7,338direct | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −2,546 | $66.85 | $170K | 8,838direct | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −5,854 | $66.03 | $387K | 11.4Kdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,300 | $64.64 | $84K | 7,238direct | Mar 15, 2019 | Mar 19, 2019 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −8,700 | $64.09 | $558K | 8,538direct | Mar 15, 2019 | Mar 19, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −200 | $68.22 | $14K | 26.5Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −2,600 | $67.73 | $176K | 26.7Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −200 | $66.45 | $13K | 29.3Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −5,000 | $68.00 | $340K | 10.9Kdirect | Mar 4, 2019 | Mar 5, 2019 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −5,000 | $66.01 | $330K | 10.9Kdirect | Mar 1, 2019 | Mar 5, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −9,000 | $65.00 | $585K | 26.5Kdirect | Feb 27, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −100 | $71.42 | $7K | 50.9Kdirect | Nov 5, 2018 | Nov 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −700 | $70.23 | $49K | 51.0Kdirect | Nov 5, 2018 | Nov 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −2,200 | $69.44 | $153K | 51.7Kdirect | Nov 5, 2018 | Nov 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −21 | $71.77 | $2K | 50.9Kdirect | Oct 5, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −1,100 | $71.05 | $78K | 51.0Kdirect | Oct 5, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −979 | $69.47 | $68K | 52.1Kdirect | Oct 5, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −900 | $68.56 | $62K | 53.0Kdirect | Oct 5, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −152 | $76.45 | $12K | 0direct | Sep 28, 2018 | Feb 20, 2019 | Form 4 ↗ |
| MARAGANORE JOHNDirector | Sale Amended | −0 | — | — | 36.2Kdirect | Sep 12, 2018 | Nov 6, 2018 | Form 4 ↗ |
| MARAGANORE JOHNDirector | Sale | −14.2K | $71.74 | $1.0M | 22.0Kdirect | Sep 12, 2018 | Sep 13, 2018 | Form 4 ↗ |
| MARAGANORE JOHNDirector | Sale | −2,400 | $73.82 | $177K | 36.2Kdirect | Sep 11, 2018 | Sep 13, 2018 | Form 4 ↗ |
| MARAGANORE JOHNDirector | Sale | −11.2K | $72.52 | $809K | 38.6Kdirect | Sep 11, 2018 | Sep 13, 2018 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −312 | $83.00 | $26K | 152direct | Sep 5, 2018 | Sep 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −100 | $84.38 | $8K | 57.2Kdirect | Sep 5, 2018 | Sep 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −2,260 | $83.17 | $188K | 57.3Kdirect | Sep 5, 2018 | Sep 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −640 | $82.52 | $53K | 59.6Kdirect | Sep 5, 2018 | Sep 7, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,700 | $80.03 | $136K | 924direct | Aug 30, 2018 | Aug 31, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −300 | $80.00 | $24K | 924direct | Aug 29, 2018 | Aug 31, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $74.92 | $154K | 0direct | Aug 24, 2018 | Aug 28, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −600 | $80.87 | $49K | 57.2Kdirect | Aug 6, 2018 | Aug 8, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −2,100 | $80.15 | $168K | 57.8Kdirect | Aug 6, 2018 | Aug 8, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −300 | $78.32 | $23K | 59.9Kdirect | Aug 6, 2018 | Aug 8, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $84.58 | $173K | 0direct | Jul 25, 2018 | Jul 27, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −800 | $87.26 | $70K | 924direct | Jul 10, 2018 | Jul 12, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,200 | $86.42 | $104K | 1,724direct | Jul 10, 2018 | Jul 12, 2018 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −272 | $84.94 | $23K | 0direct | Jul 9, 2018 | Jul 11, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −300 | $84.32 | $25K | 57.2Kdirect | Jul 5, 2018 | Jul 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −2,700 | $83.41 | $225K | 57.5Kdirect | Jul 5, 2018 | Jul 9, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $97.58 | $200K | 0direct | Jun 22, 2018 | Jun 26, 2018 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −839 | $94.30 | $79K | 2,200direct | Jun 14, 2018 | Jun 18, 2018 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −5,980 | $93.78 | $561K | 3,039direct | Jun 14, 2018 | Jun 18, 2018 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −2,181 | $92.62 | $202K | 9,019direct | Jun 14, 2018 | Jun 18, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −200 | $93.37 | $19K | 881direct | Jun 12, 2018 | Jun 14, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,800 | $92.84 | $167K | 1,081direct | Jun 12, 2018 | Jun 14, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −939 | $94.28 | $89K | 57.2Kdirect | Jun 5, 2018 | Jun 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −1,259 | $93.27 | $117K | 58.1Kdirect | Jun 5, 2018 | Jun 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −802 | $92.45 | $74K | 59.4Kdirect | Jun 5, 2018 | Jun 7, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −100 | $96.91 | $10K | 0direct | Jun 1, 2018 | Jun 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −3,190 | $96.40 | $308K | 100direct | Jun 1, 2018 | Jun 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −8,200 | $95.11 | $780K | 3,290direct | Jun 1, 2018 | Jun 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −1,510 | $94.37 | $142K | 11.5Kdirect | Jun 1, 2018 | Jun 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −45.6K | $90.07 | $4.1M | 0direct | May 30, 2018 | Jun 1, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −299 | $92.03 | $28K | 0direct | May 23, 2018 | May 29, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −9,301 | $91.60 | $852K | 299direct | May 23, 2018 | May 29, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −39.8K | $90.11 | $3.6M | 9,600direct | May 23, 2018 | May 29, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $85.76 | $176K | 0direct | May 23, 2018 | May 29, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −15.2K | $90.00 | $1.4M | 57.2Kdirect | May 23, 2018 | May 29, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,160 | $85.14 | $99K | 881direct | May 11, 2018 | May 15, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −840 | $84.81 | $71K | 2,041direct | May 11, 2018 | May 15, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −2,000 | $81.38 | $163K | 881direct | May 8, 2018 | May 10, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −3,000 | $81.81 | $245K | 57.2Kdirect | May 7, 2018 | May 8, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −100 | $84.35 | $8K | 0direct | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −2,814 | $83.56 | $235K | 100direct | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −10.1K | $82.88 | $836K | 2,914direct | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $85.95 | $176K | 0direct | Apr 23, 2018 | Apr 25, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −700 | $85.68 | $60K | 881direct | Apr 12, 2018 | Apr 16, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,300 | $84.78 | $110K | 1,581direct | Apr 12, 2018 | Apr 16, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −500 | $77.17 | $39K | 57.2Kdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −800 | $76.17 | $61K | 57.7Kdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −400 | $75.04 | $30K | 58.5Kdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −1,300 | $73.90 | $96K | 58.9Kdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −2,113 | $79.49 | $168K | 0direct | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −3,390 | $78.59 | $266K | 2,113direct | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −3,340 | $77.76 | $260K | 5,503direct | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −2,600 | $76.40 | $199K | 8,843direct | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −1,557 | $75.54 | $118K | 11.4Kdirect | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $84.65 | $174K | 0direct | Mar 22, 2018 | Mar 26, 2018 | Form 4 ↗ |
| Foster-Cheek Kaye IDirector | Sale | −6,800 | $81.97 | $557K | 2,200direct | Mar 19, 2018 | Mar 21, 2018 | Form 4 ↗ |
| Scadden DavidDirector | Purchase | +200 | $83.44 | $17K | 571direct | Mar 16, 2018 | Mar 20, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −300 | $82.90 | $25K | 881direct | Mar 14, 2018 | Mar 16, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,700 | $82.23 | $140K | 1,181direct | Mar 14, 2018 | Mar 16, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −1,100 | $84.10 | $93K | 53.1Kdirect | Mar 5, 2018 | Mar 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −1,100 | $83.21 | $92K | 54.2Kdirect | Mar 5, 2018 | Mar 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −400 | $82.04 | $33K | 55.3Kdirect | Mar 5, 2018 | Mar 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −400 | $80.93 | $32K | 55.7Kdirect | Mar 5, 2018 | Mar 7, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −10.1K | $81.30 | $820K | 0direct | Mar 1, 2018 | Mar 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −2,915 | $80.38 | $234K | 10.1Kdirect | Mar 1, 2018 | Mar 5, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −2,050 | $78.63 | $161K | 0direct | Feb 22, 2018 | Feb 26, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −500 | $78.08 | $39K | 881direct | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,500 | $77.51 | $116K | 1,381direct | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −400 | $78.03 | $31K | 53.1Kdirect | Feb 5, 2018 | Feb 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −701 | $76.76 | $54K | 53.5Kdirect | Feb 5, 2018 | Feb 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −1,100 | $75.70 | $83K | 54.2Kdirect | Feb 5, 2018 | Feb 7, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −799 | $74.89 | $60K | 55.3Kdirect | Feb 5, 2018 | Feb 7, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −685 | $79.23 | $54K | 881direct | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| Bowden ChristopherChief Medical Officer | Sale | −1,315 | $78.50 | $103K | 1,566direct | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −4,460 | $79.23 | $353K | 0direct | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −8,540 | $78.50 | $670K | 4,460direct | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −2,966 | $82.22 | $244K | 0direct | Jan 26, 2018 | Jan 30, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −11.4K | $81.40 | $925K | 2,966direct | Jan 26, 2018 | Jan 30, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −9,237 | $80.35 | $742K | 14.3Kdirect | Jan 26, 2018 | Jan 30, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −20 | $80.01 | $2K | 0direct | Jan 24, 2018 | Jan 26, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −13.5K | $80.01 | $1.1M | 0direct | Jan 24, 2018 | Jan 25, 2018 | Form 4 ↗ |
| Celgene Alpine Investment Co., LLC10% owner | Purchase Amended | +851.2K | n/c | — | 1.4Mdirect | Jan 23, 2018 | Jan 31, 2018 | Form 4 ↗ |
| Hoerter Steven L.Chief Commercial Officer | Sale | −25.0K | $74.83 | $1.9M | 0direct | Jan 23, 2018 | Jan 25, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −32.9K | $80.01 | $2.6M | 0direct | Jan 23, 2018 | Jan 25, 2018 | Form 4 ↗ |
| CELGENE CORP /DE/10% owner | Purchase | +851.2K | n/c | — | 1.4Mdirect | Jan 23, 2018 | Jan 23, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −6,597 | $74.80 | $493K | 0direct | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −10.9K | $74.11 | $809K | 6,597direct | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −22.3K | $73.02 | $1.6M | 17.5Kdirect | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Schenkein David PChief Executive Officer · Director | Sale | −13.2K | $71.77 | $946K | 39.8Kdirect | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Alenson CarmanPrincipal Accounting Officer | Sale | −2,150 | $75.00 | $161K | 0direct | Jan 12, 2018 | Jan 26, 2018 | Form 4 ↗ |
| Biller ScottChief Scientific Officer | Sale | −3,000 | $65.00 | $195K | 53.1Kdirect | Jan 10, 2018 | Jan 12, 2018 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −631 | $60.45 | $38K | 79.5Kindirect | Dec 7, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −631 | $60.45 | $38K | 79.5Kdirect | Dec 7, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −288 | $59.68 | $17K | 80.1Kindirect | Dec 7, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −288 | $59.68 | $17K | 80.1Kdirect | Dec 7, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −204 | $60.01 | $12K | 80.4Kindirect | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −204 | $60.01 | $12K | 80.4Kdirect | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −254 | $58.95 | $15K | 80.6Kindirect | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Cantley Lewis Clayton Jr.Director | Sale | −253 | $58.95 | $15K | 80.6Kdirect | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →